Learn about PCOS from experts and patients and regain control of your health in the webinar that will take place on November 15th at 4:30 PM
Join us on the journey of knowledge about Polycystic Ovary Syndrome (PCOS). PCOS affects between 5 and 10% of women worldwide, and many of them face a lack of precise diagnosis and inadequate treatment.
In this webinar, Dr. Lourdes Ibáñez and Dr. Abel López-Bermejo, renowned experts in pediatric endocrinology from the Hospital Sant Joan de Déu and the Biomedical Research Institute of Girona Doctor Josep Trueta, will guide you through the essential aspects of PCOS, debunk misconceptions, and share the latest advances in its treatment.
You will have the opportunity to learn about the exciting SPIOMET4HEALTH project and how they are tirelessly working to develop the first specific treatment for PCOS.
Join us in an inspiring conversation with patients and former patients in a roundtable discussion.
Whether you are facing PCOS, have a daughter who is dealing with it, or are a healthcare professional, this event is for you.
Don’t miss out, ask your questions to the doctors, and take control of your well-being!
Register here!
This webinar will be conducted in the Catalan language.
Agenda (15/11/2023):
16.30- Welcome and introduction
16.35- Understanding Polycystic Ovary Syndrome (PCOS). Is there a treatment for PCOS? What is SPIOMET4HEALTH?
- Dr. Lourdes Ibáñez, Pediatric Endocrinologist at Hospital Sant Joan de Déu in Barcelona, Coordinator of the SPIOMET4HEALTH project.
- Dr. Abel López-Bermejo, Pediatric Endocrinologist at the Biomedical Research Institute of Girona Doctor Josep Trueta.
16.45- Roundtable discussion: Navigating the challenges of PCOS
- Paula Romero, patient currently in the final stages of the SPIOMET4HEALTH study.
- Alexandra Hervás, former PCOS patient.
- Dr. Lourdes Ibáñez, Coordinator of the SPIOMET4HEALTH project, Hospital Sant Joan de Déu, Barcelona.
- Dr. Abel López-Bermejo, Trial Coordinator in Girona, Biomedical Research Institute of Girona Doctor Josep Trueta.
